This USP 797 pharmacy blog is focused exclusively on USP 797, a pharmacy-industry regulation which was developed by U.S. Pharmacopoeia. USP 797 was developed by USP to improve the methods of compounding sterile products, so as to increase patient safety and staff safety. For more information on USP, go to www.usp.org. For additional, privately-held resources regarding USP 797 ... go to: www.usp797.org ...connect on Facebook: www.facebook.com/usp797/ ... follow on Twitter: www.twitter.com/usp797.
Technical Safety Services, Inc. (TSS) and EMLab P&K invite you to attend a complimentary webinar addressing USP 797 compliance issues on Tuesday, November 13, 2012 (9:00am-11:00am, Pacific; 12:00pm-2:00pm, Eastern). Please plan to join the webinar 15 minutes before the scheduled time.
You will gain a better understanding of the guidelines that make up USP 797, learn about the types of monitoring used to demonstrate USP 797 compliance, and discuss facility design and its implications on USP 797 compliance. Your instructors will be: Andrew King (TSS) and Dr. Joseph Manfrida (EMLab P&K).
• History and background of USP 797
• USP 797 regulation enforcement
• How to determine what types of testing are needed
• Designing and implementing a testing regimen
• Investigation and remediation of detected contamination
NOTE: TSS will provide certificates of attendance to attendees who complete the survey after the webinar.
About Andrew King (TSS)
Andrew King is the USP 797 Compliance and Engineering Specialist for Technical Safety Services, Inc., the largest cleanroom testing and certification company in the U.S. Andrew is credentialed as a Registered Cleanroom Certification Professional in Sterile Compounding (RCCP-SC) through the industry association CETA. He maintains TSS’ SOPs to ensure ongoing compliance with USP 797 standards, and leads the development of TSS’ training program for testing/certification at sterile compounding facilities.
About Joseph Manfrida, Ph.D. (EMLab P&K)
Dr. Joseph Manfrida is a consultant in the microbiology field. Dr. Manfrida was instrumental in establishing EMLab P&K's USP 797 services and was trained at the Baxa STAR Center by experts from the United States Pharmacopeia (USP) Sterile Compounding Committee. He holds a B.S. in Biology from the University of Texas and a Ph.D. in Microbiology from Arizona State University.